Quinazolines as potassium ion channel inhibitors
US9822096B2 · kind B2 · utility
4Cited by
27References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 29, 2016 |
| Grant date | Nov 21, 2017 |
| Priority date | — |
| Expiry date | Aug 29, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound of formula Iwherein A, X, Y, Z, R1 and R24 are described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, IKur-associated disorders, and other disorders mediated by ion channel function.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.